A new Phase 1b study shows that combining the novel T-cell therapy pasritamig with docetaxel produces high response rates in patients with metastatic castration-resistant prostate cancer (mCRPC). Patients receiving the combination saw PSA reductions far exceeding typical results with chemotherapy alone. About 65% achieved a 50% drop in PSA levels, and rates rose to 88% […]

A new study shows that high-dose “ablative” radiation can greatly improve outcomes for patients with large bile duct cancers, including tumors bigger than 10 cm. Researchers found that patients who received this precise, high-dose radiation along with chemotherapy lived much longer—about 28.7 months on average—compared to 11.9 months for those treated with chemotherapy alone. The

A new study finds that targeted electroacupuncture may help breast cancer survivors improve cognitive function and reduce psychological distress. In a 10-week trial, 35 survivors with symptoms like fatigue, insomnia, and “brain fog” received weekly electroacupuncture. One group was treated at neuropsychiatric-specific acupoints, while a control group received treatment at non-specific points. Patients receiving targeted